Severe Combined Immunodeficiency News and Research

RSS
Scientists identify genetic cause of rare, life-threatening immunodeficiency disorders in children

Scientists identify genetic cause of rare, life-threatening immunodeficiency disorders in children

NIH study uncovers vulnerable sites on Epstein-Barr virus protein

NIH study uncovers vulnerable sites on Epstein-Barr virus protein

CRISPR cures on the horizon: Breakthrough center aims to heal rare, deadly genetic diseases

CRISPR cures on the horizon: Breakthrough center aims to heal rare, deadly genetic diseases

Proof-of-concept study holds promise for safer gene therapy techniques for treating immunodeficiencies

Proof-of-concept study holds promise for safer gene therapy techniques for treating immunodeficiencies

New gene editing approach could revolutionize the treatment of blood disorders

New gene editing approach could revolutionize the treatment of blood disorders

Newborn screening for "bubble-baby" disease boosts survival of children

Newborn screening for "bubble-baby" disease boosts survival of children

Newborn screening facilitates early identification of infants with severe combined immunodeficiency

Newborn screening facilitates early identification of infants with severe combined immunodeficiency

Avanced genome editing technology could be used as a one-time treatment for CD3 delta SCID

Avanced genome editing technology could be used as a one-time treatment for CD3 delta SCID

Study shows vaccine-derived poliovirus in infant with severe immunodeficiency

Study shows vaccine-derived poliovirus in infant with severe immunodeficiency

The QCOVID4 algorithm developed using data from the Omicron wave identifies those at highest risk of severe COVID-19 outcomes

The QCOVID4 algorithm developed using data from the Omicron wave identifies those at highest risk of severe COVID-19 outcomes

A polymer-nanoparticle hydrogel to subcutaneously deliver broadly neutralizing antibodies against SARS-CoV-2

A polymer-nanoparticle hydrogel to subcutaneously deliver broadly neutralizing antibodies against SARS-CoV-2

Exploring the potential utility of calcium channel inhibitors in SARS-CoV-2 infection

Exploring the potential utility of calcium channel inhibitors in SARS-CoV-2 infection

Researchers report long-lasting effects of gene therapy in children with deadly immune disorder

Researchers report long-lasting effects of gene therapy in children with deadly immune disorder

Researchers identify novel disorder resulting from a mutation in AIOLOS protein

Researchers identify novel disorder resulting from a mutation in AIOLOS protein

UCSF launches new initiative to propel the development of living therapeutics

UCSF launches new initiative to propel the development of living therapeutics

Investigational gene therapy can restore immune function in children with inherited immunodeficiency disorder

Investigational gene therapy can restore immune function in children with inherited immunodeficiency disorder

Experimental gene therapy successfully treats children born without an immune system

Experimental gene therapy successfully treats children born without an immune system

Scientists launch clinical trial of CRISPR gene correction therapy in patients with sickle cell disease

Scientists launch clinical trial of CRISPR gene correction therapy in patients with sickle cell disease

New test will help better manage patients with severe combined immunodeficiency

New test will help better manage patients with severe combined immunodeficiency

Research team generates comprehensive developmental map of human T-cells

Research team generates comprehensive developmental map of human T-cells

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.